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Abstract
Background: Understanding the health profile, service and medicine use of Austra-
lians in the aged care sector will help inform appropriate service provision for our age-
ing population.
Aims: To examine the 2006–2015 trends in (i) comorbidities and frailty of individuals
accessing aged care, and (ii) health services, medicine use and mortality after entry into
long-term care.
Methods: Cross-sectional and population-based trend analyses were conducted using
the Registry of Senior Australians.
Results: From 2006 to 2015, 509 944 individuals accessed permanent residential care,
206 394 home care, 283 014 respite and 124 943 transition care. Over this time, the
proportion of individuals accessing permanent residential care with high frailty scores
(≥0.3) increased (19.7–49.7%), as did the proportion with 5–9 comorbidities (46.4–
54.5%), with similar trends observed for those accessing other services. The median
number of medicines dispensed in the year after entering permanent residential care
increased from 9 (interquartile range (IQR) 6–12) to 10 (IQR 7–14), while remaining
stable in home care (2006: 9, IQR 5–12, 2015: 9, IQR 6–13). Short-term (within 100 days)
mortality in those accessing permanent care was higher in 2006 (15.6%, 95% CI 15.2–
16.0) than 2015 (14.6%, 95% CI 14.3–14.9). Longer term (101–1095 days, 2006: 44.3%,
95% CI 43.7–45.0, 2015: 46.4%, 95% CI 45.8–46.9) mortality was higher in 2015 com-
pared to 2006. Mortality in individuals accessing home care did not change.
Conclusion: The health of older Australians accessing aged care programmes has
declined while frailty increased, with an increasing use of medicine and worse long-term
mortality in some. Funding and care models need to adapt to this changing profile.
Introduction
The Australian population is increasing, ageing, using
more healthcare and progressively needing more aged
care services.1 Between 2008 and 2016, the number of
people accessing aged care increased by 19%, but the
proportion of individuals over 65 years accessing care
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remained steady (5.4% in 2008 and 5.6% in 2016).2
This slow increase in access does not reflect the increase
in service demand, evidenced by the significant long wait
lists for services.3
Government subsidised Residential Aged Care in
Australia was rolled out in 1963, followed by Commu-
nity Aged Care, and Home and Community Care
programmes in the 1990s and the Aged Care Act
1997.4 Since the Aged Care Act, programmes and poli-
cies supporting residential and home-based aged care
service provision have been implemented, evolved,
replaced or retired. For example, the Aged Care
Assessment Program was introduced in 2003, the
Extended Aged Care at Home programme in 2002, the
Transition Care Program for restorative services in
2005 and the Extended Aged Care at Home pro-
gramme for people living with dementia in 2006.5 In
2013 the Home Care Package programme was changed
to a four-level programme and the ‘extended’
programmes were retired,6 in 2015 the Community
Home and Support Programme replaced the Home and
Community Care programme and in 2016 Consumer
Directed Care for home packages and the MyAgedCare
platform were introduced.7 During these changes the
cohort of people accessing aged care has been moni-
tored8,9 and few studies have evaluated the burden of
certain conditions in this population.10,11 The overall
population level health, frailty profile, healthcare ser-
vice utilisation and specific outcomes of those entering
aged care have not been examined, especially relating
to trends over time.
In 2017, the Registry of Senior Australians (ROSA)
established the linkage of information from the aged care
and healthcare sectors, so the experience, overall health
profile and service utilisation of individuals navigating
these two sectors could be investigated.12 ROSA contains
a Historical Cohort (1997–2017) with 2.9 million indi-
viduals and a Prospective South Australian Cohort
(2018-onwards, ~16 000 annual entries), which together
are a national resource for understanding consumers of
aged care and their outcomes.
Using ROSA, we examined the major Australian pop-
ulation-based trends between 2006 and 2015 in
(i) health status and frailty of individuals accessing aged
care, and (ii) health services, medicine use and mortality
after entry into long-term care.
Methods
A cross-sectional evaluation and population-based
trend analysis were conducted using data from the
Historical Cohort of ROSA (1997–2017), which in its
entirety includes older individuals accessing aged care
services in Australia. Over 1.2 million of the individ-
uals in ROSA accessed aged care services between
2002 and 2017 for which an aged care eligibility
assessment by an Aged Care Assessment Team (ACAT)
is required.
The ROSA contains de-identified linked information
from the Australian Institute of Health and Welfare
(AIHW) National Aged Care Data Clearinghouse
(NACDC), and Australian Government Medicare Bene-
fits Schedule (MBS), and Pharmaceutical Benefits
Scheme (PBS). From the NACDC, the Aged Care
Assessment Program (ACAP), Aged Care Funding
Instrument (ACFI), episodes of Residential Aged Care
Services, episodes of Community Aged Care Packages,
episodes of Home Care Packages and National Death
Index (NDI) datasets were used. The ACAP dataset
includes information on the person seeking services,
assessor and recommended services. The ACFI dataset
provides information on the care needs assessment per-
formed at permanent residential care entry. The epi-
sodes of care datasets provide details on services
received. The NDI dataset provides dates and causes of
death. The MBS dataset provides information on Aus-
tralian Commonwealth subsidised healthcare services.
The PBS dataset provides information on medicines
provided under the PBS and Repatriation PBS. The
linkage report from AIHW indicated that the aged care
cohorts were linked to the Medical Enrolment File with
linkage rates of 99.5% for residential aged care and
home care package recipients, and 99% for aged care
eligibility assessment individuals, indicating high
matching rates between the aged care and MBS and
PBS datasets.
Non-indigenous individuals ≥65 years old who
received permanent residential care, home care and
respite care for the first time between 1 January 2006
and 31 December 2015 were included in this study due
to complete national implementation of the ACAP. Tran-
sition care was introduced nationally gradually from
2005; therefore, individuals with transition care service
between 1 January 2007 and 31 December 2015 were
included.
To describe the individuals accessing services, sex, age
and country of birth were obtained from eligibility
assessments. Index of Relative Socio-Economic Disad-
vantage and Index of Education and Occupation and
remoteness status were obtained by linking the individ-
uals’ post codes to the 2016 Australian Bureau of Statis-
tics Socio-Economic Indexes for Areas and to the
Accessibility/Remoteness Index of Australia Plus 2016,
respectively.13,14 Concession and Department of Vet-
erans’ Affairs card status were determined from PBS
records. To ascertain individuals’ health status we used
Health status in Australian aged care
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the medicine-based comorbidity measure RxRisk-V
(6 months lookback period).15 To ascertain dementia,
we used any indication of dementia in the eligibility
assessments or the RxRisk-V, except for those entering
permanent residential care, where the entry into care
assessment was also used. Frailty status was ascertained
using a frailty index developed for the aged care eligibil-
ity assessment dataset.16
To evaluate trends in healthcare service use after
long-term care (i.e. permanent residential and home
care only) entry the MBS dataset was used. Most com-
monly used services in the 1-year after service entry
were identified. As individuals with DVA benefits use
MBS services differently, the health services analysis
only included non-DVA card holders. The types of ser-
vices examined included professional attendances
(codes A*) and use of major MBS groups, including
diagnostic procedures and investigations (codes D01*),
therapeutic procedures (codes T08*), diagnostic imag-
ing services (codes I0*) and miscellaneous services
(M0*). Using the PBS dataset, medicines used in the
year after long-term care entry were identified. Mortal-
ity and cause of death were stratified into short-term
(0–100 days after entry) and long-term (101–1095 days
after entry); see Table A1 for all MBS, PBS and NDI
codes used.
Analyses were stratified by care received (not mutu-
ally exclusive): permanent residential, home, respite and
transition care. Descriptive statistics characterised the
cohorts. The yearly prevalence of health conditions,
frailty status, health services use and medicine use were
calculated. Direct standardisation (reference year = 2010)
was used to estimate age and sex adjusted yearly preva-
lence rates of health services, medicine uses and mortal-
ity rates after entry into care. Kaplan–Meier curves
described survival after entry into care. SAS 9.4 (SAS Insti-
tute, Cary, NC, USA) was employed.
Results
Between 2006 and 2015, 509 944 individuals accessed
permanent residential care, 206 394 accessed home care,
283 014 accessed respite and 124 943 accessed transition
care. Individuals accessing any services in 2015 were
slightly older than those in 2006 and the proportion of
females had decreased over time. Table 1 shows cohort
characteristics.
Both in 2006 (or 2007 for transition) and 2015 the
median number of comorbidities for the cohorts was
5 (interquartile range (IQR) 3–7, although permanent
residential IQR increased to 4–7 in 2015) except for
those in transition care, which increased to 6 (IQR 4–8)
in 2015. The proportion of individuals with 5–9
comorbidities increased in all services (Table 1), with
the biggest increases seen for those accessing perma-
nent residential (46.4–54.5%) and home care (47.2–
53.5%). While the prevalence of dementia in those
accessing all services decreased (Table 1), the preva-
lence of gastro-oesophageal reflux disease, hyper-
lipidaemia, hypertension, ischaemic heart disease,
depression and pain increased between 2006 and 2015
(Table A2, Fig. 1, Supporting Information Fig. S1).
The proportion of individuals with a higher frailty
index score (≥0.3) increased in all services between 2006
and 2015 (Table 1), including from 19.7% to 49.7% for
those accessing permanent residential care and from
15% to 51.1% in those accessing home care.
In individuals accessing permanent residential or
home care between 2006 and 2015, increases in the age
and sex adjusted prevalence of primary care and preven-
tative services were observed, including use of
optometrical services, urgent attendance after hours and
general practitioner management plans (Figs 2,S2,
Table A3). The use of cardiovascular diagnostic proce-
dures and investigations, diagnostic radiology, and allied
health services increased in those accessing home and
permanent residential care, while surgical operations
remained similar (Figs 2,S2, Table A3).
The median number of medicines dispensed within
1 year of entering permanent residential care was 9 (IQR
6–12) in 2006 and 10 (IQR 7–14) in 2015, and for those
entering home care it was 9 (IQR 5–12) in 2006 and 9 (IQR
6–13) in 2015. Of the 10 most frequently dispensed medi-
cines in the first year of permanent residential care, the age
and sex adjusted use between 2006 and 2015 of paraceta-
mol (68.4–74.4%), macrogol (8.8–35.9%), cefalexin
(28.1–31.0%), pantoprazole (12.0–25.0%), oxycodone
(11.2–23.1%), atorvastatin (11.9–18.4%) and risperidone
(13.6–15.9%) increased, while aspirin (31.0–26.6%) and
temazepam (28.6–18.8%) decreased. Out of the 10 most
frequently dispensed medicines for those in home care,
use of paracetamol (46.6–53.0%), macrogol (4.9–17.9%),
cefalexin (25.1–28.0%), pantoprazole (12.7–23.2%), ator-
vastatin (18.2–24.1%), metoprolol (11.9–16.0%) and
esomeprazole (13.3–21.1%) increased and aspirin
(27.8–18.0%), temazepam (20.3–13.2%) and peri-
ndopril (15.1–13.2%) decreased between 2006 and
2015 (Figs 3,S3, Table A3).
Overall survival is lower in those in permanent care
than living in the community with home care packages
(Fig. S4). For those in residential care the age and sex
adjusted short-term mortality rate was higher in 2006
(15.6%, 95% CI 15.2–16.0) than 2015 (14.6%, 95% CI
14.3–14.9), while the long-term mortality rate was
slightly higher in more recent years (2006: 44.3%, 95%
CI 43.7–45.0; 2014: 46.4%, 95% CI 45.8–46.9) (Table 2).
Inacio et al.
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Cancer, coronary heart disease, dementia and Alzheimer
disease, cerebrovascular disease and chronic obstructive
pulmonary disease were the most common causes of
short- and long-term deaths, both in 2006 and
2014/2015.
For those entering home care services, neither short-
(2006: 4.4%, 95% CI 4.4–5.0; 2015: 5.0%, 95% CI 4.8–
5.3) nor long-term (2006: 35.6%, 95% CI 34.7–36.5;
2014: 35.0%, 95% CI 34.2–35.8) mortality rates chan-
ged during the study period (Table 2, Fig. S4). The main
causes of death (short- or long-term) also did not change
(Table 2).
Discussion
In a decade, while the median age has increased slightly,
the health and frailty status of Australians accessing vari-
ous aged care programmes have worsened considerably.
This reflects the increasing use of these programmes by
people with higher burdens of illness and frailty. Corre-
spondingly, polypharmacy was common and increased
over time, highlighting potential areas of opportunity for
improvement through appropriate prescribing. Subse-
quent to entry into long-term care, the most commonly
used healthcare services highlight increasing access to
preventive and disease management related services and
Figure 1 Ten most prevalent health condi-
tions and trends in individuals entering perma-
nent residential care. ( ), Anticoagulants;
( ), antiplatelets; ( ), chronic airways
disease; ( ), congestive heart failure;
( ), depression; ( ), gastro-oesophageal
reflux disease; ( ), hyperlipidaemia; ( ),
hypertension; ( ), ischaemic heart disease:
hypertension; ( ), pain.
Figure 2 Ten most commonly used healthcare services by individuals in the first year after entering permanent residential care, age and sex adjusted
prevalence. Does not include ‘General practitioner attendances to which no other item applies’, which >96.6% of the cohort has every year. ( ),
Optometrical services; ( ), urgent attendance after hours; ( ), health assessments; ( ), GP and multidisciplinary care plans; ( ), medica-
tion management reviews; ( ), GP after hours attendances; ( ), cardiovascular diagnostic procedures; ( ), diagnostic radiology; ( ), allied
health services; ( ), surgical operations.
Inacio et al.
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afterhours services. Finally, a modest increase in long-
term mortality after entering permanent residential care
was observed, while the main reasons for death
remained similar.
Our study describes the increasingly high burden of
frailty and comorbidities in individuals accessing aged
care services. The high frailty estimates in our cohort
falls within the range reported by others.17–19 However,
the observed 2.2–3.4-fold increase in higher scores over
this decade has not been reported. This greater burden
of frailty has implications for policy and funding deci-
sions relating to aged care services given that frailty is
associated with higher care needs and indicates a vul-
nerability to health stressors where health intervention
may be required.20 Our estimates of high mul-
timorbidity confirm findings from smaller cohorts of
older Australians in the community and in residential
care.15,21,22 Most individuals in our cohort had five or
more comorbidities (median = 5), which is higher than
that reported in the Australian Longitudinal Study of
Ageing (median = 2) but similar to the Department of
Veterans’ Affairs (median = 5) cohorts, using similar
comorbidity measures to our study.15,22 Gastro-
oesophageal reflux disease, hypertension, ischaemic
heart disease, depression and pain were five of the
seven most prevalent conditions in 2006 and 2015 and
conditions that increased during the period. Dementia,
as previously reported, is one of the most common con-
ditions affecting these individuals, but the prevalence of
dementia at the point of entry into care has
decreased.10 Our national comorbidity estimates are in
line with studies of the general and older Australian
population, and agree with prior reports of increases in
gastro-oesophageal reflux disease, depression and
pain.1,23,24 However, decreases in cardiovascular
disease in older individuals have been reported, which
is contrary to our observations.25 These changes in mul-
timorbidity and frailty, along with the previously
reported trends in demographics, limitations and higher
care level needs of individuals accessing permanent
care,2,9 highlight the need for substantial planning for
individuals with greater needs entering care.
In accord with the increasing frailty and morbidity of
individuals accessing aged care services, professional
attendances are increasingly frequent. Increases in the
use of optometrical services, health assessments, man-
agement plans, collaborative medicine reviews, along
with allied health services are necessary as these are
likely beneficial for older individuals.26–29 The use of
these preventative services and timely management of
conditions can contribute to reduced reliance on more
expensive care. Increases in after hours attendances and
cardiovascular diagnostic procedures and investigations
were also observed, which are in line with national
increases.30,31 The national increase in after hours atten-
dances was investigated by a MBS Review Taskforce,
which found no clinical reasons for this and determined
the changes were likely due to business practices.30 MBS
changes were implemented in March 2018 to address
this and their impact remains to be determined. Small
increases in diagnostic radiology use in this cohort may
be reflective of the stable incidence rates of fractures in
older individuals, a partial driver for the use of these ser-
vices.32 Finally, the proportion of individuals undergoing
surgical operations has not changed, despite small
national increases in surgeries, which is likely due to
these cohorts’ advanced age and frailty.33
Polypharmacy in individuals in long-term care is com-
mon. Additionally, the most commonly used medicines
point to areas of concern both surrounding the care for
Figure 3 Ten most commonly dispensed med-
icines for individuals in the first year after
entering permanent residential care, age and
sex adjusted prevalence. ( ), Paracetamol;
( ), furosemide; ( ), acetylsalicylic acid;
( ), cefalexin; ( ), macrogol; ( ),
temazepam; ( ), oxycodone; ( ), pan-
toprazole; ( ), atorvastatin; ( ),
risperidone.
Health status in Australian aged care
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Table 2 Age and sex adjusted short and long term mortality rate and cause specific mortality after entering long term service, by service accessed
and by year
Service
Permanent residential care Home care
2006 2015 2006 2015
Total, n 42 801 (100.0) 56 846 (100.0) 16 578 (100.0) 24 830 (100.0)
Short-term causes of death (0–100 days after entry)†, % (CI)
Total deaths 15.6 (15.2,16.0) 14.6 (14.3,14.9) 4.4 (4.1,4.8) 5.0 (4.8,5.3)
Neoplasms 4.1 (3.9,4.3) 4.4 (4.2,4.6) 1.2 (1.1,1.4) 1.8 (1.6,2.0)
Coronary heart disease 2.8 (2.6,2.9) 1.8 (1.7,1.9) 0.9 (0.8,1.1) 0.7 (0.6,0.8)
Dementia and Alzheimer disease 0.9 (0.8,1.0) 1.3 (1.2,1.4) 0.1 (0.1,0.2) 0.2 (0.1,0.3)
Cerebrovascular disease 1.7 (1.6,1.8) 1.1 (1.0,1.2) 0.3 (0.2,0.4) 0.3 (0.2,0.4)
Chronic obstructive pulmonary disease 0.8 (0.7,0.9) 0.8 (0.7,0.8) 0.2 (0.1,0.3) 0.3 (0.2,0.4)
Other 0.6 (0.5,0.7) 0.7 (0.6,0.8) 0.3 (0.2,0.4) 0.4 (0.3,0.4)
Other circulatory system diseases 0.6 (0.5,0.7) 0.5 (0.5,0.6) 0.2 (0.1,0.3) 0.2 (0.1,0.2)
Diabetes 0.5 (0.4,0.6) 0.5 (0.4,0.6) 0.1 (0.1,0.2) 0.1 (0.1,0.1)
Diseases of the genitourinary system 0.6 (0.6,0.7) 0.4 (0.4,0.5) 0.1 (0.1,0.2) 0.2 (0.1,0.2)
Heart failure or heart disease 0.5 (0.4,0.6) 0.4 (0.4,0.5) 0.1 (0.1,0.2) 0.1 (0.1,0.2)
Other respiratory diseases 0.5 (0.4,0.5) 0.4 (0.4,0.5) 0.2 (0.1,0.3) 0.2 (0.2,0.3)
Diseases of the digestive system 0.3 (0.3,0.4) 0.4 (0.3,0.4) 0.1 (0.1,0.2) 0.1 (0.1,0.2)
Cardiac arrhythmias 0.2 (0.2,0.3) 0.3 (0.3,0.4) 0.0 (0.0,0.0) 0.1 (0.0,0.1)
Influenza and pneumonia 0.4 (0.4,0.5) 0.3 (0.3,0.4) 0.1 (0.1,0.2) 0.1 (0.0,0.1)
Accidental falls 0.2 (0.1,0.2) 0.3 (0.2,0.3) 0.0 (0.0,0.1) 0.1 (0.0,0.1)
Parkinson disease 0.3 (0.2,0.3) 0.2 (0.2,0.3) 0.1 (0.0,0.1) 0.1 (0.0,0.1)
Hypertensive disease 0.1 (0.1,0.2) 0.2 (0.2,0.3) 0.0 (0.0,0.1) 0.0 (0.0,0.0)
Other endocrine nutrition and metabolic diseases 0.1 (0.1,0.2) 0.2 (0.2,0.2) 0.1 (0.0,0.1) 0.1 (0.0,0.1)
Other external causes 0.1 (0.1,0.2) 0.1 (0.1,0.2) 0.0 (0.0,0.0) 0.0 (0.0,0.1)
Musculoskeletal system and connective tissue diseases 0.2 (0.1,0.2) 0.1 (0.1,0.2) 0.1 (0.0,0.1) 0.1 (0.0,0.1)
Unknown cause 0.0 (0.0,0.0) 0.0 (0.0,0.0) 0.0 (0.0,0.0) 0.0 (0.0,0.0)
2006 2014‡ 2006 2014‡
Long-term causes of death (101–1095 days after entry)†, % (CI)
Total deaths 44.3 (43.7,45.0) 46.4 (45.8,46.9) 35.6 (34.7,36.5) 35.0 (34.2,35.8)
Dementia and Alzheimer disease 5.7 (5.5,6.0) 8.4 (8.2,8.7) 3.3 (3.0,3.6) 4.4 (4.1,4.7)
Coronary heart disease 8.5 (8.2,8.8) 6.0 (5.8,6.2) 6.7 (6.3,7.1) 4.5 (4.2,4.7)
Neoplasms 5.5 (5.3,5.7) 5.8 (5.6,6.0) 5.6 (5.2,6.0) 5.9 (5.6,6.2)
Cerebrovascular disease 6.0(5.7,6.2) 4.6(4.4,4.8) 3.8(3.5,4.1) 2.8(2.6,3.0)
Chronic obstructive pulmonary disease 1.8 (1.7,2.0) 2.6 (2.4,2.7) 1.7 (1.5,1.9) 2.0 (1.8,2.2)
Other 2.0 (1.8,2.1) 2.5 (2.3,2.6) 1.7 (1.5,1.9) 2.2 (2.0,2.4)
Diabetes 1.7 (1.5,1.8) 1.7 (1.5,1.8) 1.5 (1.3,1.7) 1.2 (1.0,1.3)
Unknown cause 1.2 (1.1,1.3) 1.5 (1.4,1.6) 0.7 (0.6,0.8) 1.0 (0.8,1.1)
Influenza and pneumonia 1.5 (1.4,1.6) 1.5 (1.4,1.6) 1.6 (1.4,1.8) 1.5 (1.4,1.7)
Other circulatory system diseases 1.3 (1.2,1.4) 1.4(1.3,1.5) 1.4(1.2,1.6) 1.2(1.1,1.4)
Other respiratory diseases 1.6(1.4,1.7) 1.4 (1.3,1.5) 1.2 (1.1,1.4) 1.0(0.8,1.1)
Diseases of the digestive system 1.4(1.3,1.6) 1.4(1.3,1.5) 1.4(1.2,1.5) 1.3 (1.1,1.4)
Diseases of the genitourinary system 1.5 (1.4,1.6) 1.3 (1.2,1.4) 1.3 (1.2,1.5) 1.1 (1.0,1.2)
Heart failure or heart disease 0.9 (0.8,1.0) 1.1 (1.1,1.2) 0.8 (0.6,0.9) 0.9 (0.8,1.0)
Parkinson disease 0.5 (0.5,0.6) 1.0 (0.9,1.1) 0.6 (0.5,0.7) 0.8 (0.7,0.9)
Cardiac arrhythmias 0.7 (0.6,0.8) 1.0 (0.9,1.1) 0.5 (0.4,0.6) 0.7 (0.6,0.8)
Accidental falls 0.9 (0.8,1.0) 1.0 (0.9,1.1) 0.5 (0.4,0.6) 0.7 (0.6,0.8)
Hypertensive disease 0.1 (0.0,0.1) 0.7 (0.7,0.8) 0.0 (0.0,0.0) 0.7 (0.6,0.8)
Other external causes 0.6(0.5,0.6) 0.6(0.5,0.6) 0.5(0.4,0.6) 0.6(0.5,0.7)
Musculoskeletal system and connective tissue diseases 0.6 (0.5,0.7) 0.5 (0.5,0.6) 0.4 (0.3,0.5) 0.3 (0.2,0.4)
Other endocrine nutrition and metabolic diseases 0.5 (0.4,0.5) 0.5 (0.5,0.6) 0.3 (0.3,0.4) 0.5 (0.4,0.5)
†To ensure the cohort had a minimum 365 days of follow up the 2014 cohort long-term mortality was evaluated only. ‡Unknown/not stated cause of
death: <0.1% of cohort for short-term causes of death, <2% for long-term causes of death. CI, confidence interval.
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individuals in this sector and national trends.34–37 For
example, an antibiotic was the third most commonly pre-
scribed medicine in long-term care, highlighting the
importance of antibiotic stewardship and infection control
practices, which is now a national quality standard
requirement for residential care facilities.38 The common
use of risperidone, while in line with other estimates from
residential care facilities37 and with increases in the gen-
eral population during a similar period,39 confirms con-
cerns of its overuse. Encouragingly, recent reports note a
national decrease in risperidone use for dementia related
symptoms since 2015; however, this remains to be exam-
ined in the national cohort of individuals accessing aged
care.40 The common and increased use of proton pump
inhibitors pantoprazole and esomeprazole41 and opioid
oxycodone,42 both agree with growing national concerns
regarding over-prescription of these medicines and their
related harm. The five-fold increase in use of macrogol, a
laxative, is potentially related to side-effects of other med-
icine use (e.g. opioids),43 and reflects the changes in its
PBS restriction level in 2007. Atorvastin and perindropril,
which were the two most commonly prescribed medi-
cines in the Australian PBS in 2015, have also increased
in use in the cohort of people in long-term care.35 Meto-
prolol, a beta blocker, commonly used in those in home
care has also increased in use by individuals in long-term
care, which could be an indication of better management
of secondary prevention of heart failure.44 Of note,
temazepam use decreased, a trend also reported in the
general population during this period.39,45 Aspirin use
also decreased, especially after 2013, which may be a
result of increasing evidence of low benefits and potential
risks associated its use for prevention of cardiovascular
disease during this time,46a trend likely to continue.
Overall causes of short- and long-term mortality in
individuals accessing aged care services are comparable
to national estimates.47 Our evaluation of short- com-
pared to long-term mortality highlighted that approxi-
mately 15% of individuals die shortly after entering
residential care, which is significantly higher than the
3% reported to be receiving palliative care.48 Given this
finding, permanent residential care needs to be consid-
ered an essential part of palliative care provision and
the delivery of these services should be supported
appropriately. Previous Australian residential aged care
research also suggests that advance care planning for
those most frail could contribute to reduced hospital
presentation and increased likelihood of dying in place
as opposed to the unfamiliar hospital environment.49
Slight increases in longer-term mortality after perma-
nent residential care entry over the years were noted
and this could be related to the increase in comorbidity
and frailty of the cohort.
Our study uses the ROSA datasets, which rely on
linked data from various Australian Government
datasets and suffers from the common observational
studies’ limitations, especially regarding its internal
validity. However, much of the data used is mandatorily
collected, and in some cases by trained/accredited pro-
fessionals (i.e. ACAT). While the ACAP data collection
tool remained consistent over the study period, we
examined potential changes in data collection processes
over the years by looking for significant changes in
prevalence of health conditions and functional limita-
tions, which were found to have changed gradually
over the study period. However, it is possible that the
increase in prevalence of health conditions and func-
tional limitations of the cohort is due to changes in
diagnostic criteria or recording practices. Our frailty
estimates are also based on a cumulative deficit index
derived measure, which uses the existing aged care eli-
gibility assessment data and not a clinician administered
frailty instrument.16 We are limited in our ability to
comment on the indications for medicines or services
obtained, therefore only age and sex adjusted trends
are discussed and not treatment appropriateness.
Restrictions of subsidies for certain services, for exam-
ple medicine reviews changed from being rec-
ommended yearly to every 2 years and pharmacist-
initiated reviews no longer being acceptable more
recently, may have led to changes in access to services.
However, even with these restrictions, more individuals
accessed these services in recent years. We cannot com-
ment on medicine intake and adherence, as this is not
available in our data sources, or treatment outcomes, as
these were not evaluated in this study. Because trends
for specific medicines and not classes were analysed,
changes should be interpreted with care, for example a
decline in temazepam use does not represent a decrease
in benzodiazepine use. Additionally, medicines avail-
able without a prescription and inexpensive were likely
underestimated in our study, and those dispensed dur-
ing a hospitalisation were not captured. Finally, we
have limited our investigation to the most commonly
used healthcare services and medicines; therefore, we
cannot comment on practice changes that occurred in
less frequent events.
Strengths of our study include a population-based
cohort of individuals accessing aged care services for a
contemporary period in Australia. Ours is a national
longitudinal study with limited loss to follow
up. Finally, our study derived new information from
the linkage of the aged care and healthcare datasets
captured within the ROSA database that allowed for a
comprehensive examination into the main trends
affecting individuals in aged care.
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Conclusion
We have determined that the population entering aged
care programmes have worse health status and more
frailty in more recent years. Funding and care models
need to adapt to this changing profile, so they can
translate into better overall care and reduced reliance
on secondary and tertiary care. Models of care that
focus on appropriate prescribing, including reduced
antipsychotic use and antibiotic stewardship, as well as
advance care planning could improve care outcomes
for older individuals accessing aged care programmes in
Australia.
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Appendix I
Table A1 Health services, medicines and causes of death coding
Description Code
Health services MBS group or subgroup code
General practitioner attendances to which no other item applies A01
Optometrical services A10
Urgent attendance after hours A11
Health assessments A14
General practitioner management plans, team care arrangements, multidisciplinary care plans A15
Domiciliary and residential management reviews A17
Medical practitioner (emergency physician) attendances to which no other item applies A21
General practitioner after hours attendances to which no other item applies A22
Cardiovascular diagnostic procedures and investigations D0106
Diagnostic radiology I03
















Causes of death ICD-10-AM
Neoplasms C00-D48
Diabetes E10-E14
Other endocrine nutrition and metabolic diseases E00-E90, excluding E10-E14
Dementia and Alzheimer disease F00-F03, G30
Parkinson disease G20-G22
Hypertensive disease I10-I15
Coronary heart disease I20-I25
Cardiac arrhythmias I47-I49
Heart failure or heart disease I50-I51
Cerebrovascular disease I60-I69, G45-G46
Other circulatory system diseases I00-I99 excluding I10-I15, I20-I25, I47-I51,I60-I69
Influenza and pneumonia J09-J18
Chronic obstructive pulmonary disease J40-J44
Other respiratory diseases J00-J99, excluding J09-J18, J40-J44
Diseases of the digestive system K00-K93
Musculoskeletal system and connective tissue diseases M00-M99
Diseases of the genitourinary system N00-N99
Accidental falls W00-W19
Other external causes V01-Y98, excluding W00-W19
Unknown cause R95-R99, missing
Other Any code not included above
ATC, Anatomical, Therapeutic and Chemical Classification; ICD-10-AM, International Statistical Classification of Diseases, 10th Revision, Australian Modi-
fication; MBS, Medicare Benefits Schedule.
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Supporting Information
Additional supporting information may be found in the online version of this article at the publisher’s web-site:
Figure S1 Ten most prevalent health conditions and trends in individuals entering home care.
Figure S2 Ten most commonly used healthcare services (not including ‘General practitioner attendances to which no
other item applies’, which >96.6% of the cohort has every year) by individuals in the first year after entering home
care, age and sex adjusted prevalence.
Figure S3 Ten most commonly dispensed medicines for individuals in the first year after entering home care, age and
sex adjusted prevalence.
Figure S4 Kaplan–Meier curve of survival after entry into permanent residential care and home care, by whether indi-
viduals entered care in 2006 and 2014.
Table A3 Age and sex adjusted healthcare and medicine use after entry into permanent residential care or home care, by service accessed and
by year
Service
Permanent residential care Home care
2006 2015 2006 2015
Total, n 42 801 (100.0) 56 846 (100.0) 16 578 (100.0) 24 830 (100.0)
Total N excluding DVA card holders† 33 955 (79.3) 48 872 (86.0) 13 985 (84.4) 23 381 (94.2)
Healthcare services‡, prevalence (95% CI)
General practitioner attendances to which no other item
applies
96.6 (95.5,97.6) 96.6 (95.7,97.5) 96.9 (95.2,98.5) 97.3 (96.1,98.6)
General practitioner after hours attendances to which no
other item applies
25.2 (24.6,25.7) 53.0 (52.3,53.6) 13.8 (13.2,14.4) 25.7 (25.1,26.4)
General practitioner management plans, team care
arrangements, multidisciplinary care plans
17.8 (17.4,18.3) 47.1 (46.4,47.7) 24.8 (23.9,25.6) 57.3 (56.3,58.3)
Optometrical services 37.0 (36.3,37.6) 45.9 (45.3,46.5) 30.3 (29.4,31.2) 40.2 (39.4,41.1)
Collaborative domiciliary and residential management reviews 18.3 (17.8,18.8) 45.5 (44.9,46.1) 5.4 (5.0,5.8) 11.0 (10.6,11.4)
Health assessments 31.4 (30.8,32.0) 45.4 (44.8,46.0) 25.2 (24.3,26.0) 31.1 (30.4,31.9)
Urgent attendance after hours 35.5 (34.8,36.1) 40.7 (40.1,41.3) 15.6 (15.0,16.3) 19.7 (19.1,20.3)
Diagnostic radiology 30.8 (30.2,31.4) 31.6 (31.1,32.1) 42.2 (41.1,43.3) 46.1 (45.2,47.0)
Allied health services 5.2 (5.0,5.5) 28.0 (27.5,28.5) 8.6 (8.1,9.1) 44.0 (43.1,44.9)
Surgical operations 20.0 (19.5,20.5) 19.9 (19.5,20.3) 32.8 (31.8,33.8) 33.7 (32.9,34.5)
Cardiovascular diagnostic procedures and investigations 13.8 (13.4,14.3) 17.1 (16.8,17.5) 25.7 (24.9,26.6) 34.8 (34.0,35.6)
Medicines, prevalence (95% CI)
Median number (IQR) 9 (6,12) 10 (7,14) 9 (5,12) 9 (6,13)
Paracetamol 68.4 (67.6,69.3) 74.4 (73.6,75.1) 46.6 (45.5,47.8) 53.0 (52.0,54.0)
Furosemide 34.3 (33.7,34.9) 33.6 (33.1,34.1) 32.9 (31.9,33.9) 31.6 (30.8,32.3)
Acetylsalicylic acid 31.0 (30.4,31.5) 26.6 (26.1,27.0) 27.8 (27.0,28.7) 18.0 (17.4,18.5)
Cefalexin 28.1 (27.5,28.6) 31.0 (30.5,31.5) 25.1 (24.2,25.9) 28.0 (27.3,28.7)
Macrogol 8.8 (8.5,9.1) 35.9 (35.3,36.4) 4.9 (4.5,5.3) 17.9 (17.3,18.5)
Temazepam 28.6 (28.1,29.1) 18.8 (18.4,19.2) 20.3 (19.5,21.1) 13.2 (12.7,13.7)
Oxycodone§ 11.2 (10.8,11.5) 23.1 (22.7,23.6) 8.2 (7.8,8.7) 13.4 (13.0,13.9)
Pantoprazole 12.0 (11.7,12.4) 25.0 (24.6,25.5) 12.7 (12.1,13.3) 23.2 (22.5,23.8)
Atorvastatin 11.9 (11.6,12.3) 18.4 (18.1,18.8) 18.2 (17.5,18.9) 24.1 (23.4,24.7)
Risperidone§ 13.6 (13.3,14.0) 15.9 (15.6,16.3) 5.7 (5.3,6.1) 5.9 (5.6,6.2)
Esomeprazole§ 11.3 (10.9,11.6) 16.5 (16.1,16.8) 13.3 (12.6,13.9) 21.1 (20.4,21.7)
Metoprolol 10.6 (10.3,10.9) 15.4 (15.1,15.7) 11.9 (11.3,12.5) 16.0 (15.4,16.5)
Perindopril§ 14.0 (13.6,14.4) 11.7 (11.4,12.0) 15.1 (14.5,15.8) 13.2 (12.7,13.7)
†For details on Australian Government Department of Veterans’ Affairs Health Cards, refer to https://www.dva.gov.au/sites/default/files/files/providers/
hospitals/dvacards.pdf. ‡Healthcare services were examined in the non-DVA cohort only. §Oxycodone and risperidone are part of the 10 most fre-
quently prescribed medicines for residential care only. Esomeprazole and perindopril are part of the 10 most frequently prescribed medicines for
home care only. CI, confidence intervals; DVA, Department of Veterans’ Affairs; IQR, interquartile range.
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